Call for Papers

The AHLI Conference on Health, Inference, and Learning (CHIL) solicits work across a variety of disciplines at the intersection of machine learning and health. CHIL 2027 invites submissions focused on artificial intelligence and machine learning (AI/ML) techniques that address opportunities and challenges in health, which we view broadly as including clinical healthcare, public health, population health, and beyond.

Important Dates

MilestoneDate
OpenReview accounts created for all authorsFriday, January 15, 2027
Submissions dueWednesday, February 3, 2027
Bidding opens for reviewersEarly Feb 2027
Bidding closes for reviewersEarly to mid-Feb 2027
Reviews assignedWednesday, February 10, 2027
Reviews dueTuesday, March 2, 2027
Reviews releasedFriday, March 12, 2027
Author/reviewer discussionFriday, March 26, 2027
Meta-review deadlineFriday, April 2, 2027
Author notificationMonday, April 12, 2027
CHIL conferenceJune 28–30, 2027

Topics of Interest

CHIL invites submissions on a broad range of topics at the intersection of machine learning and health, including but not limited to:

  • Technical contributions: modeling, inference, and estimation in health-focused or health-inspired settings.
  • Applied and evaluative research: applying, characterizing, auditing, evaluating, and benchmarking ML approaches to healthcare problems.
  • Societal impacts: effects of health AI on clinical practice, patient experience, access, costs, and equity, responsible design, implementation, and oversight.

Submission Format and Guidelines

Submission Site

Submissions should be made via OpenReview (conference submission link to follow). All authors must have an OpenReview account with a complete profile to support conflict-of-interest checks.

Account approval can take up to two weeks, so please register by January 15 to ensure you can submit by the February 3 deadline.

Length and Formatting

Submitted papers must be 8-10 pages (including all figures and tables); an Overleaf template is available here. Unlimited additional pages can be used for references and additional supplementary materials (e.g. appendices). Reviewers will not be required to read the supplementary materials.

Double Blind Peer Review Policy

The review process is mutually anonymous (aka “double blind”). Your submitted paper, as well as any supporting text or revisions provided during the discussion period, should be completely anonymized (including links to code repositories). Please do not include any identifying information, and refrain from citing the authors’ own prior work in anything other than third-person. Violations of this anonymity policy at any stage before final manuscript acceptance decisions may result in rejection without further review. Conference organizers and reviewers are required to maintain confidentiality of submitted material. Upon acceptance, the titles, authorship, and abstracts of papers will be released prior to the conference.

Required Sections

Three sections will be required at the end of the manuscript and will not count toward page limits: 1) Data and Code Availability, 2) Institutional Review Board (IRB), 3) Statement on AI Use. If any of the sections are missing or not anonymized, the conference organizers reserve the right to desk-reject the submission.

Data and Code Availability: This section should include:

  1. What data you use (including citations if appropriate) and whether the data are or will be made available to other researchers. If it is private data, you should describe the data vaguely and without citation, e.g. reference as “data from an anonymous health system”, to avoid de-anonymization during the review phase.
  2. Computer software submissions should include an anonymized code link (e.g. https://anonymous.4open.science/) or code attached as supplementary material, licensing information, and provide documentation to facilitate use and reproducibility (e.g., package versions, README, intended use, and execution examples that facilitate execution by other researchers). If you are not sharing code at the time of submission, you must explicitly state that you are not making your code available.

Institutional Review Board (IRB): This initial section is required. You should list one of the below, alongside a one-sentence explanation of why your research falls into that category:

  • “The research does not require IRB approval”
  • “This research has been designated by our IRB as Not Human Subject Research”
  • “This research has been approved by our IRB, and we will add the IRB institution and number upon acceptance.”

For guidance on whether IRB approval is required, please consult your local Institutional Review Board (or equivalent ethics committee). In the U.S., authors may find the Office for Human Research Protections (OHRP) decision charts helpful: https://www.hhs.gov/ohrp/regulations-and-policy/decision-charts-2018/.

Statement on AI Usage: All submissions must include a Statement on AI Use, which does not count toward the page limit. This statement should disclose any use of AI tools in experimentation, analysis, or manuscript preparation. Spell checkers and grammar suggestions do not need to be disclosed. For each use, state the tool and version, the task, and how the authors verified the output. If no AI tools were used, state “None.” We recommend following the format of the ICLR 2027 AI Policy for Authors.

Archival Submissions and Dual Submission Policy

Submissions to the main conference are considered archival and will appear in the published proceedings of the conference, if accepted. Authors will be notified of acceptance by the date listed under Important Dates.

You may not submit papers that are identical, or substantially similar to versions that are currently under review at another conference or journal, have been previously published, or have been accepted for publication. Submissions to the main conference are considered archival and will appear in the published proceedings of the conference if accepted.

An exception to this rule is extensions of workshop papers that have previously appeared in non-archival venues, such as workshops, arXiv, or similar without formal proceedings. These works may be submitted as-is or in an extended form, though they must follow our manuscript formatting guidelines. CHIL also welcomes full paper submissions that extend previously published short papers or abstracts, so long as the previously published version does not exceed 4 pages in length. Note that the submission should not cite the workshop/report and preserve anonymity in the submitted manuscript.

Preprint Submission Policy

Submissions to preprint servers (such as ArXiv or MedRxiv) are allowed while the papers are under review. While reviewers will be encouraged not to search for the papers, you accept that uploading the paper may make your identity known.

Registration Information

To promote community interaction, at least one author of each accepted paper is required to register for, attend, and present the work at the conference in order for the paper to appear in the conference proceedings. This policy is subject to change. Registration details are forthcoming.

Reciprocal Reviewing Requirement

To support a high-quality and equitable review process amidst increasing submission volumes, AHLI has a reciprocal review policy.

Every submission must nominate one co-author of the submission to serve as its reciprocal reviewer. The nominated author will review a minimum of three papers, and authors nominated for multiple submissions may be assigned more. Authors serving as Area Chairs, Senior Area Chairs, or in other organizing roles for CHIL 2027 are exempt from this requirement.

Nominated reviewers must be a first or last author on at least one prior archival publication at a comparable peer-reviewed venue (e.g. a ML for health conference or journal, or a health-focused paper at an ML venue). Below is a list of qualifying venues:

  • Machine learning for biomedicine: CHIL, ML4H Proceedings, MLHC Proceedings, MICCAI, PSB, ISMB, MIDL
  • Statistics: JASA, Biostatistics, Statistics in Medicine
  • Core machine learning: NeurIPS, ICML, ICLR, AISTATS, UAI, TMLR, JMLR, AAAI, IJCAI, KDD, ACL, EMNLP, NAACL, ACM FAccT, CVPR, ECCV, COLM, Nature Machine Intelligence
  • Informatics: AMIA Annual Symposium, JAMIA, JAMIA Open, Journal of Biomedical Informatics, Journal of Medical Internet Research, JMIR AI
  • Clinical: NEJM, The Lancet, JAMA, Annals of Internal Medicine, JAMA Internal Medicine, Nature Medicine, The Lancet Digital Health, NEJM AI, PLOS Digital Health, npj Digital Medicine, JAMA Network Open, and the top three venues in each medical specialty subcategory listed on Google Scholar
  • Multidisciplinary: Nature Communications, Science Advances, PNAS

If you believe a venue not listed here should qualify, submit a request through a form (coming soon!) with the venue name at least one week before the submission deadline.

We welcome and encourage submissions from first-time contributors at CHIL. If none of the authors meet this qualification, you may claim this exemption on the submission form, and the submission will be exempt from this requirement. No author may be on more than one submission that claims this exemption. If an author appears on more than one such submission, we reserve the right to desk reject all of them.

If the nominated reviewer does not accept their reviewer invitation, reviews are not submitted by the deadline, or the reviews fail to meet a quality bar, the corresponding submission of the nominated reviewer may be subject to desk rejection. Exceptions may be granted at the discretion of the organizers.

Policy on Author Use of Large Language Models

Authors are welcome to use tools that support high-quality research and paper preparation, provided their use complies with applicable rules and regulations, including those governing data use. It is crucial to meet two primary expectations. Firstly, authors must ensure methodological clarity to maintain scientific rigor and transparency. Detail the use of Large Language Models (LLMs) within the experimental setup (or equivalent) if they are a significant or innovative part of the approach. Secondly, authors bear full responsibility for all paper content, including text, figures, and references. While any tool can be used for preparation and writing, guaranteeing the accuracy and originality of all content is paramount. We note that papers that are fully AI-generated are unlikely to meet the quality and clarity bar required to be accepted to CHIL.

All submissions must include a Statement of AI Use (see Required Sections above). This statement should describe whether and how LLMs or other AI tools were used, both in the research itself and in preparing the manuscript. If no such tools were used, the statement should say so.

All authors are fully responsible for understanding the pros and cons of any tools used in publications, especially regarding data retention and privacy. Be aware that some API-based tools may use inputs for model training. High-level instructions can cause errors in plots, potentially harming scientific integrity. Authors must verify tools are used responsibly.

Finally, authors may not insert hidden prompts, instructions, or other manipulations in their manuscripts intended to influence AI-based review systems. Attempts to do so will be treated as a breach of publication ethics and grounds for rejection or retraction.

CHIL may conduct investigations regarding adherence to the Code of Conduct at any point, even after paper acceptance, publication, or the conference itself. In the event of a violation, CHIL retains the right to retract a paper’s publication. Violations can include, but are not limited to, scientifically unsound content, such as hallucinated results from LLMs, or utilizing references produced by an LLM without verifying their accuracy, existence, or suitability within the manuscript’s context.

Evaluation

Desk Rejection

Submissions that do not meet the requirements below may be rejected without full review. Desk rejection protects reviewers’ time for papers that are ready to be evaluated. It can happen at any point in the review process.

  • Severe lack of clarity. The writing is so unclear, verbose, or unfocused that reviewers cannot reasonably assess the contribution. These issues are common in AI-generated text that has not been carefully edited. Minor language or grammar issues are not grounds for desk rejection.
  • Fundamental technical flaws. The submission has errors that invalidate its main claims and are evident without detailed review.
  • Anonymity. The submission reveals author identity, for example through names, affiliations, acknowledgments, non-anonymized code or data links, or self-citations written in the first person.
  • Formatting. The submission does not use the CHIL template, exceeds the page limit, alters margins, fonts, or spacing, or omits required sections, including the Statement on AI Use.
  • Scope. The submission falls outside CHIL’s scope, for example work with no health application or no substantive computational contribution.
  • Dual submission or plagiarism. The submission is substantially similar to work published or under review at another archival venue, or to another CHIL submission.
  • Reviewing obligations. Each submission’s designated reciprocal reviewer must complete their assigned reviews on time and to an acceptable standard. A submission may be desk-rejected if its nominated reciprocal reviewer fails to submit reviews, or submits reviews that the area chair judges to be negligent. Negligent reviews include cursory or generic reviews and reviews produced in violation of the reviewer AI policy. This may happen after reviews of the submission have been received.
  • Fabricated or manipulative content. The submission contains references that do not exist or hidden prompts or other manipulations.

We may use software tools, including AI tools that do not retain submissions for training, to help flag potential issues. However, all desk rejections will be reviewed manually by multiple members of the organizing committee.

Review Policy

Submissions that are not desk rejected will be reviewed by at least 3 reviewers. Detailed reviewer instructions and evaluation criteria will be posted later. Reviewers will be asked to primarily judge the work according to the following criteria:

Relevance: Is the submission relevant to health, broadly construed? Does the problem addressed fall into the domains of machine learning and health?

Quality: Is the submission technically sound? Are claims well supported by theoretical analysis or experimental results? Are the authors careful and honest about evaluating both the strengths and weaknesses of their work? Is the work complete rather than a work in progress?

Originality: Are the tasks, methods and results novel? Is it clear how this work differs from previous contributions? Is related work adequately cited to provide context? Does the submission contribute unique data, unique conclusions about existing data, or a unique theoretical or experimental approach?

Clarity: Is the submission clearly written? Is it well-organized? Does it adequately provide enough information for readers to reproduce experiments or results?

Significance: Is the contribution of the work important? Are other researchers or practitioners likely to use the ideas or build on them? Does the work advance the state of the art in a demonstrable way?

Reproducibility: Will the data and code be released? How easy would it be for others to re-implement and reproduce the approach? Are datasets cited and described, including cohort demographics, subgroup statistics, and train/validation/test splits?

Ethical Data Handling: For data involving human subjects, does the submission describe data acquisition and report ethics oversight (e.g., IRB approval or exemption, informed consent or a waiver, data use agreements)?

Final decisions will be made by the CHIL Organizing Committee, taking into account reviewer comments, ratings of confidence and expertise, and our own editorial judgment. Reviewers will be able to flag submissions for ethical issues, relevance, and suitability concerns.

Open Access

CHIL is committed to open science and ensuring our proceedings are freely available.

Data Use Policy

All AHLI-organized events, including CHIL 2027, are subject to AHLI’s Data Use Policy, which governs how submission and review data may be used for operational purposes.

Contact Us

Please direct questions to: chil@ahli.cc and follow us on Bluesky at @ahli-cc.bsky.social or on X at @CHILconference.